title: A proteomic comparison of formalin-fixed paraffin-embedded pancreatic tissue from autoimmune pancreatitis, chronic pancreatitis, and pancreatic cancer.
abstract: BACKGROUND
  Formalin-fixed paraffin-embedded (FFPE) tissue is a standard for specimen preservation, and as such FFPE tissue banks are an untapped resource of histologically-characterized specimens for retrospective biomarker investigation for pancreatic disease.
  
  
  OBJECTIVE
  We use liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) to compare FFPE specimens from three different diseases of the exocrine pancreas.
  
  
  METHODS
  We investigated the proteomic profile of FFPE pancreatic tissue from 9 archived specimens that were histologically classified as: autoimmune pancreatitis (n=3), chronic pancreatitis (n=3), and pancreatic cancer (n=3), using LC-MS/MS.
  
  
  METHODS
  This is a proteomic analysis experiment of FFPE pancreatic tissue in an academic center.
  
  
  METHODS
  FFPE tissue specimens were provided by Dana-Farber/Harvard Cancer Center (Boston, MA, USA).
  
  
  METHODS
  FFPE tissue specimens were collected via routine surgical resection procedures.
  
  
  METHODS
  We compared proteins identified from chronic pancreatitis, autoimmune pancreatitis, and pancreatic cancer FFPE pancreatic tissue.
  
  
  RESULTS
  We identified 386 non-redundant proteins from 9 specimens. Following our filtering criteria, 73, 29, and 53 proteins were identified exclusively in autoimmune pancreatitis, chronic pancreatitis, and pancreatic cancer specimens, respectively.
  
  
  CONCLUSIONS
  We report that differentially-expressed proteins can be identified among FFPE tissues specimens originating from individuals with different histological diagnoses. These proteins merit further confirmation with a greater number of specimens and orthogonal validation, such as immunohistochemistry. The mass spectrometry-based methodology used herein has the potential to enhance diagnostic biomarker and therapeutic target discovery, further advancing pancreatic research.
authors.affiliation: Department of Pathology, Brigham and Women's Hospital and Department of Medicine, Harvard Medical School. Boston, MA 02115, USA. dconwell@partners.org
authors.forename: Joao A
authors.initials: JA
authors.lastname: Paulo
authors.forename: Vivek
authors.initials: V
authors.lastname: Kadiyala
authors.forename: Scott
authors.initials: S
authors.lastname: Brizard
authors.forename: Peter A
authors.initials: PA
authors.lastname: Banks
authors.forename: Hanno
authors.initials: H
authors.lastname: Steen
authors.forename: Darwin L
authors.initials: DL
authors.lastname: Conwell
mesh_terms: D001327:Autoimmune Diseases / Q000175:diagnosis / Q000378:metabolism*; D002853:Chromatography, Liquid; D015331:Cohort Studies; D005557:Formaldehyde; D006801:Humans; D007150:Immunohistochemistry; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000378:metabolism*; D010195:Pancreatitis / Q000175:diagnosis / Q000378:metabolism*; D050500:Pancreatitis, Chronic / Q000175:diagnosis / Q000378:metabolism*; D016612:Paraffin Embedding / Q000379:methods; D020543:Proteome / Q000032:analysis* / Q000145:classification; D040901:Proteomics / Q000379:methods*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D053719:Tandem Mass Spectrometry; D016707:Tissue Fixation / Q000379:methods
chemical_list: D020543:Proteome; D005557:Formaldehyde